Additional file 1 of O-GlcNAcylation expression predicts a favorable prognosis and mitigates malignant phenotypes via MYCN suppression in neuroblastoma

Supplementary Material 1. Supplementary Fig. 1: Correlation of O-GlcNAc positivity with clinical features in neuroblastoma patients. Bar graph showing the percentage of high O-GlcNAc expression in patient subgroups stratified by MYCN amplification status (Non-amplified vs. Amplified) and tumor histology (Differentiated vs. Undifferentiated). Statistical significance was determined using Pearson's chi-square test (***P < 0.001, *P < 0.05). Data are derived from Table 1.